ACCESSWIRE
25 Nov 2021, 18:05 GMT+10
LUND, SWEDEN / ACCESSWIRE / November 25, 2021 / BioInvent International (STO:BINV)
Lund, Sweden - November 25, 2021 - The members of the Nomination Committee for BioInvent International AB:s (publ) ('BioInvent') Annual General Meeting in 2022 have now been appointed.
The following representatives of BioInvent International AB's shareholders will be members of the Nomination Committee for the Annual General Meeting 2022:
The Nomination Committee shall prepare proposals for the Annual General Meeting in 2022 regarding Chairman of the General Meeting, Chairman of the Board and other Board members, board remuneration shared among the Chairman and other Board members, possible compensation for committee work, and election of auditors and auditor's fees.
The Annual General Meeting will be held on April 28, 2022 in Lund, Sweden.
Proposals to the Nomination Committee can be sent to Stefan Ericsson, by mail: BioInvent International AB (publ).), SE-223 70 Lund or telephone: +46 (0)46-46 286 85 50 in good time before March 10, 2022
For further information, please contact:
Cecilia Hofvander
Senior Director Investor Relations
Tel: +46 46 286 85 50
Email. [email protected]
BioInvent International AB (publ)
Co. Reg. No. Org nr: 556537-7263
Visiting address: Ideongatan 1
Mailing address: 223 70 LUND
Phone: +46 (0)46 286 85 50
www.bioinvent.com
About BioInvent
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The Company's validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline or for additional licensing and partnering.
The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com. Follow us on Twitter: @BioInvent.
SOURCE: BioInvent International
Get a daily dose of Tennessee Daily news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Tennessee Daily.
More InformationNEW YORK, New York - U.S. stocks wavered on Thursday as strong economic data gave further impetus to the Fed ...
AUGUSTA, Maine: On April 12, the Maine Legislature passed a bill to join an interstate compact for social worker licensure ...
AUSTIN, Texas: Reuters reported this week that Tesla will make more than 10 percent of its global workforce redundant amid ...
WASHINGTON, D.C.: On April 13, U.S. Steel shareholders voted in favor of the company's proposed US$14.9 billion acquisition by Japan's ...
NEW YORK, New York - A downturn in Nvidia, and a continuation of Tuesday's sell-off following Fed Chairman Jerome Powell's ...
SAN FRANCISCO, California: Wells Fargo reported a seven percent decline in first-quarter profit, surpassing analysts' forecasts despite increased costs associated ...
AUGUSTA, Maine: On April 12, the Maine Legislature passed a bill to join an interstate compact for social worker licensure ...
AUSTIN, Texas: Reuters reported this week that Tesla will make more than 10 percent of its global workforce redundant amid ...
BOISE, Idaho: Idaho authorities said that four people died when the vehicle they were traveling in collided with a train ...
WASHINGTON, D.C.: On April 13, U.S. Steel shareholders voted in favor of the company's proposed US$14.9 billion acquisition by Japan's ...
DENVER, Colorado: On April 14, Colorado's Democratic-controlled House passed a bill by a vote of 35-27 banning the sale and ...
COLUMBIA, South Carolina: Federal prosecutors said that Christine Mary Livingston, supervisor in a South Carolina prison, accepted more than US$219,000 ...